Trial of Vision Therapy for Intermittent Exotropia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-16
SponsorSouthern California College of Optometry at Marshall B. Ketchum University

About this trial

The main objective of this randomized trial comparing vision therapy to observation is to determine the short-term effectiveness of vision therapy on distance intermittent exotropia control. The results will help determine whether to proceed to a full-scale, long-term randomized trial.

Eligibility criteria

Qualifiers

Age 8 - 16 years

Distance exodeviation of 15∆ to 35∆ by prism alternating cover test (PACT)

IXT, exophoria, or orthophoria at near

Near exodeviation that does not exceed the distance exodeviation by more than 10∆

Disqualifiers

Treatment for IXT or amblyopia (other than refractive correction) within 3 months prior to enrollment

Office-based vision therapy for IXT within 6 months prior to enrollment

Prior office-based vision therapy for IXT of ≥10 sessions

Prior strabismus, intraocular, or refractive surgery (including BOTOX injection)

Trial design

Treatments tested in this trial

  • Vision Therapy

Treatment groups

58 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Southern California College of Optometry at Marshall B. Ketchum University

Lead sponsor

Stanford University

Collaborator

Ohio State University

Collaborator

Salus University

Collaborator

University of Alabama at Birmingham

Collaborator

Southern College of Optometry

Collaborator

Case Western Reserve University

Collaborator

American Academy of Optometry

Collaborator